Home
>
National Drug Code (NDC)
>
NEVANAC
NEVANAC - 0065-0002-03 - (nepafenac)
Drug Information of NEVANAC
| Product NDC: | 0065-0002 |
| Proprietary Name: | NEVANAC |
| Non Proprietary Name: | nepafenac |
| Active Ingredient(s): | 1 mg/mL & nbsp; nepafenac |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NEVANAC
| Product NDC: | 0065-0002 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021862 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050906 |
Package Information of NEVANAC
| Package NDC: | 0065-0002-03 |
| Package Description: | 3 mL in 1 BOTTLE, PLASTIC (0065-0002-03) |
NDC Information of NEVANAC
| NDC Code | 0065-0002-03 |
| Proprietary Name | NEVANAC |
| Package Description | 3 mL in 1 BOTTLE, PLASTIC (0065-0002-03) |
| Product NDC | 0065-0002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nepafenac |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20050906 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | NEPAFENAC |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
